Abstract
Candida auris has been recognised as a problematic healthcare-associated emerging yeast which is often misidentified as Candida haemulonii by commercial systems. Correct early identification of C. auris is important for appropriate antifungal treatment and implementing effective infection control measures. Here we report emergence of the first C. auris cases in Oman, initially misidentified as C. haemulonii.
| Original language | English |
|---|---|
| Pages (from-to) | 569-575 |
| Number of pages | 7 |
| Journal | Mycoses |
| Volume | 60 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - Sept 2017 |
| Externally published | Yes |
Keywords
- Aged
- Antifungal Agents/pharmacology
- Candida/classification
- Candidemia/diagnosis
- Candidiasis/epidemiology
- Communicable Diseases, Emerging/microbiology
- Female
- High-Throughput Nucleotide Sequencing
- Humans
- Male
- Microbial Sensitivity Tests
- Molecular Typing
- Oman/epidemiology
- Phylogeny